Safety and Clinical Activity of a Combination Therapy Comprising Two Antibody-Based Targeting Agents for the Treatment of Non-Hodgkin Lymphoma: Results of a Phase I/II Study Evaluating the Immunoconjugate Inotuzumab Ozogamicin With Rituximab
JOURNAL OF CLINICAL ONCOLOGY. Bd. 31. H. 5. 2013 S. 573-583
Erscheinungsjahr: 2013
Publikationstyp: Zeitschriftenaufsatz
| Geprüft: | Bibliothek |
Autoren
Fayad, Luis (Autor)
Offner, Fritz (Autor)
Smith, Mitchell R. (Autor)
Verhoef, Gregor (Autor)
Johnson, Peter (Autor)
Kaufman, Jonathan L. (Autor)
Rohatiner, Ama (Autor)
Advani, Anjali (Autor)
Foran, James (Autor)
Hess, Georg (Autor)
Coiffier, Bertrand (Autor)
Czuczman, Myron (Autor)
Gine, Eva (Autor)
Durrant, Simon (Autor)
Kneissl, Michelle (Autor)
Luu, Kenneth T. (Autor)
Hua, Steven Y. (Autor)
Boni, Joseph (Autor)
Vandendries, Erik (Autor)
Dang, Nam H. (Autor)
Klassifikation
DDC Sachgruppe:
Medizin
